146 research outputs found

    Thorough elucidation of synthesis and structure of poly(glycerol) functionalized nanodiamonds

    Get PDF
    Poly(glycerol) (PG) is one of the most promising platforms for the surface modification of nanomaterials especially for in vivo applications. Since the “grafting-from” process is facile to functionalize the nanomaterial surface covalently through the ring-opening polymerization of glycidol (GD), it has been applied to a variety of nanomaterials. The resulting numerous hydroxy groups in the hyperbranched structure serve as scaffolds for further functionalization and provide good dispersibility under physiological conditions. On the other hand, nanodiamond (ND) is a nanomaterial most intensely worked with PG because of its prominent properties including fluorescence from color centers. Despite the wide-spread use, the process has not been extended to be scalable and controllable. In addition, the structural details of PG chain on ND surface are yet elusive. In this work, we develop more scalable and safer PG functionalization of NDs by dropwise-addition of GD to ethylene glycol (EG) suspension of ND. The resulting PG amount can be controlled or even estimated by the reaction conditions (weights of GD, ND and EG) and the ND properties (diameter and oxygen content). The structure of PG chain was qualitatively and quantitatively analyzed by ¹³C nuclear magnetic resonance (NMR) and dynamic light scattering (DLS) measurements. Based on these results, the structure of PG is elucidated

    Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations

    Get PDF
    ObjectiveTo compare the clinical outcome between ultrasound-guided foam sclerotherapy (UGFS) and ultrasound-guided liquid form sclerotherapy (UGLS) in patients with venous malformations (VM).MethodsEighty-nine patients with symptomatic VM were treated with ultrasound-guided sclerotherapy. There were 22 males and 67 females with mean age of 14.5 years. The sclerosing agents used were 1% polidocanol (POL) or 10% ethanolamine oleate (EO). POL was injected predominantly into smaller, superficial lesions, whereas EO was used for large, deeper lesions. Foam sclerosing solution was provided using Tessari’s method. Patients were randomized to receive either UGFS or UGLS. Post-sclerotherapy surveillance was done at 6 months after last session using duplex ultrasound. Findings obtained by duplex scanning were divided into four groups: (1) disappeared group: the venous space was occluded and was totally shrunk; (2) partially recanalized group: the venous space was partially recanalized and was partially shrunk; (3) totally recanalized group: the venous space was totally recanalized and returned at the same size; and (4) worsened group: the venous space was totally recanalized and became worse.ResultsForty-nine patients were treated with UGFS and the remaining 40 were treated with UGLS. There were no significant differences in age and men:women ratio. There was no significant difference in the anatomic distribution of VMs between the two groups. The amount of POL was significantly smaller in patients who were treated with UGFS (P = .022). Similarly, there was a significant reduction in the use of EO in patients treated with UGFS (P = .005). The proportion of VM with total disappearance and partial recanalization was significantly higher in patients treated with UGFS (P = .002). No major complications related to sclerotherapy were encountered in both groups.ConclusionsThese findings suggest that UGFS could have greater promise compared with UGLS in the treatment of VMs

    Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII

    Get PDF
    Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: Comparison with apoprotein CIII.BackgroundRecent studies have suggested that apoprotein (apo) CI in very low-density lipoprotein (VLDL) plays an important role in causing hypertriglyceridemia independent of apo CIII, which is associated with coronary heart disease (CHD). Because the incidence of CHD is increased in diabetic patients and is even higher when diabetic nephropathy is developed, we measured apo CI levels in VLDL from type 2 diabetic patients, with various degree of nephropathy, and compared the results with those for healthy controls or nondiabetic patients with chronic renal failure (CRF).MethodsThis study enrolled healthy control subjects, type 2 diabetic patients with normoalbuminuria, microalbuminuria, overt proteinuria, and CRF on hemodialysis and nondiabetic hemodialyis patients. VLDL (density <1.006) was separated by ultracentrifugation. Then the apo CI, CIII, and B concentrations in VLDL were measured by enzyme-linked immunosorbent assay (ELISA).ResultsThe apo CI, CIII, and B concentrations in VLDL were respectively 3-, 2-, and 2-fold higher, respectively, in diabetic patients with overt proteinuria than in controls. Hemodialysis patients with diabetic nephropathy had levels of apo CI, CIII, and B in VLDL that were 2.6-, 2.7- and 2-fold higher, respectively, than those in controls. Nondiabetic hemodialysis patients also had a 2.7-fold higher level of VLDL apo CIII, whereas VLDL apo CI and VLDL apo B were not significantly increased. VLDL apo CI was significantly correlated with VLDL apo B independently of VLDL apo CIII level.ConclusionAn increase of VLDL apo CIII is a prominent feature of dyslipidemia in CRF patients, regardless of whether they are diabetic or nondiabetic, whereas an increase of VLDL apo CI is more specific to diabetic nephropathy and is closely associated with an increase of VLDL particle numbers, a new risk factor for CHD

    Environmental Control of Annual Reproductive Cycle and Spawning Rhythmicity of Spinefoots

    Get PDF
    Proceedins of 8th Kuroshio University League Network Formation Toward the Sustainable Society in Kuroshio Region Through Cross-Boader Educatio
    corecore